KLOW

Description

KLOW is a co-formulated research blend consisting of four separate peptides: GHK-Cu, BPC-157, TB-500, and KPV.

GHK-Cu is a copper-binding tripeptide studied extensively in extracellular-matrix and cellular signaling research. BPC-157 has primarily been investigated in experimental models involving tissue and vascular biology. TB-500 is a synthetic peptide associated with research into thymosin-beta-4-related cellular processes and cell migration. KPV is a short peptide fragment derived from alpha-melanocyte-stimulating hormone and has been studied in inflammatory signaling models.

The combination is designed as a multi-pathway research formulation rather than a single peptide. The four components remain chemically distinct within the blend, allowing researchers to investigate overlapping cellular pathways involving matrix biology, inflammatory signaling, and tissue-related processes.

The supplied formulation contains GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, and KPV 10 mg, for 80 mg total peptide content in a 3 mL lyophilized vial.

Research Use Only. Not for Human or Veterinary Use. These products are not intended to diagnose, treat, cure, or prevent any disease. Product information is provided for research and educational purposes only.